ATE490468T1 - Verfahren zur unterscheidung von wenigstens zwei zellpopulationen und anwendung - Google Patents

Verfahren zur unterscheidung von wenigstens zwei zellpopulationen und anwendung

Info

Publication number
ATE490468T1
ATE490468T1 AT06841854T AT06841854T ATE490468T1 AT E490468 T1 ATE490468 T1 AT E490468T1 AT 06841854 T AT06841854 T AT 06841854T AT 06841854 T AT06841854 T AT 06841854T AT E490468 T1 ATE490468 T1 AT E490468T1
Authority
AT
Austria
Prior art keywords
covering
populations
total quantity
markers
qncm
Prior art date
Application number
AT06841854T
Other languages
English (en)
Inventor
Francis Lacombe
Francis Belloc
Sylvie Veriac
Didier Lefevre
Original Assignee
Horiba Abx Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horiba Abx Sas filed Critical Horiba Abx Sas
Application granted granted Critical
Publication of ATE490468T1 publication Critical patent/ATE490468T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/016—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1006—Investigating individual particles for cytology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1477—Multiparameters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ecology (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06841854T 2005-12-20 2006-12-05 Verfahren zur unterscheidung von wenigstens zwei zellpopulationen und anwendung ATE490468T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0512948A FR2895087B1 (fr) 2005-12-20 2005-12-20 Methode de discrimination d'au moins deux populations cellulaires et application
PCT/FR2006/002645 WO2007080245A1 (fr) 2005-12-20 2006-12-05 Methode de discrimination d'au moins deux populations cellulaires et application

Publications (1)

Publication Number Publication Date
ATE490468T1 true ATE490468T1 (de) 2010-12-15

Family

ID=36259085

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06841854T ATE490468T1 (de) 2005-12-20 2006-12-05 Verfahren zur unterscheidung von wenigstens zwei zellpopulationen und anwendung

Country Status (14)

Country Link
US (1) US8080383B2 (de)
EP (1) EP1963859B1 (de)
JP (1) JP4782844B2 (de)
KR (1) KR20080082650A (de)
CN (1) CN101375164B (de)
AT (1) ATE490468T1 (de)
BR (1) BRPI0620212B8 (de)
CA (1) CA2632343A1 (de)
DE (1) DE602006018653D1 (de)
ES (1) ES2357035T3 (de)
FR (1) FR2895087B1 (de)
RU (1) RU2397494C2 (de)
WO (1) WO2007080245A1 (de)
ZA (1) ZA200804642B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2935802B1 (fr) * 2008-09-05 2012-12-28 Horiba Abx Sas Procede et dispositif de classification, de visualisation et d'exploration de donnees biologiques
JP5452058B2 (ja) * 2009-03-31 2014-03-26 シスメックス株式会社 血液分析装置
FR2956207B1 (fr) 2010-02-10 2012-05-04 Horiba Abx Sas Dispositif et procede de mesures multiparametriques de microparticules dans un fluide
US20120173296A1 (en) * 2011-01-03 2012-07-05 Mcmullin Dale Robert Method and system for outage restoration
RU2513511C1 (ru) * 2012-12-19 2014-04-20 Федеральное государственное бюджетное учреждение "Российский онкологический научный центр имени Н.Н. Блохина" Российской академии медицинских наук (ФГБУ "РОНЦ им. Н.Н. Блохина" РАМН) Способ количественного определения клеток-предшественников (cd34+) в кроветворной ткани
US20140349313A1 (en) * 2013-04-30 2014-11-27 Becton, Dickinson And Company Data analysis methods utilizing phenotypic properties
CN104792751B (zh) * 2015-04-02 2017-06-23 清华大学 通过荧光共振能量转移方法原位定量活细胞中的蛋白质‑蛋白质相互作用
CN108732082A (zh) * 2018-06-07 2018-11-02 北京唯公医疗技术有限公司 细胞分群方法
US11428692B2 (en) 2018-07-11 2022-08-30 Visiongate, Inc. Specimen enrichment for optical tomography cell analysis
US10753875B1 (en) * 2019-01-31 2020-08-25 Rarecyte, Inc. Spectral unmixing of spectroscopic emission images
CN110231275B (zh) * 2019-05-20 2021-05-28 西安交通大学 一种基于流式细胞术检测nk细胞杀伤活性的方法
CN117890335B (zh) * 2023-12-01 2024-08-02 山东省大健康精准医疗产业技术研究院 一种基于氮掺杂碳量子点荧光探针检测微生物活性的试剂盒及其检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016314A1 (en) * 1993-01-08 1994-07-21 Coulter Corporation Method of using preserved control cells in the calibration of fluorescent and light scatter measurements
GR940100272A (en) * 1993-06-08 1995-11-29 Ortho Diagnostic Systems Inc Three-colour flow cytometry with automatic gating function.
US6900023B1 (en) * 1999-09-02 2005-05-31 Sysmex Corporation Method for classifying and counting leukocytes
US20030134305A1 (en) * 2001-08-16 2003-07-17 Dertinger Stephen D. Method for the enumeration of mammalian micronucleated erythrocyte populations with a single-laser flow cytometer
US7625712B2 (en) * 2004-05-21 2009-12-01 Beckman Coulter, Inc. Method for a fully automated monoclonal antibody-based extended differential

Also Published As

Publication number Publication date
EP1963859B1 (de) 2010-12-01
EP1963859A1 (de) 2008-09-03
CA2632343A1 (fr) 2007-07-19
ES2357035T3 (es) 2011-04-15
CN101375164A (zh) 2009-02-25
BRPI0620212B1 (pt) 2018-02-14
RU2008129429A (ru) 2010-01-27
RU2397494C2 (ru) 2010-08-20
WO2007080245A1 (fr) 2007-07-19
ZA200804642B (en) 2009-04-29
BRPI0620212B8 (pt) 2021-07-27
JP4782844B2 (ja) 2011-09-28
CN101375164B (zh) 2014-01-01
JP2009520198A (ja) 2009-05-21
FR2895087B1 (fr) 2008-02-08
US8080383B2 (en) 2011-12-20
KR20080082650A (ko) 2008-09-11
DE602006018653D1 (de) 2011-01-13
US20090311678A1 (en) 2009-12-17
FR2895087A1 (fr) 2007-06-22
BRPI0620212A2 (pt) 2013-01-15

Similar Documents

Publication Publication Date Title
ZA200804642B (en) Method of discriminating at least two cell populations, and application
DE602005013225D1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
AR096319A2 (es) Método y kit de detección de adn en una muestra que comprende adn de maíz y sonda de adn útil en dicho método
WO2008105896A3 (en) Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
IL252832B (en) Use of biomarkers for detecting ovarian cancer
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
ATE421092T1 (de) Verwendung von gfap zum nachweis von intrazerebraler blutung
WO2005073408A3 (en) Small segments of dna determine animal identity and source
NZ596163A (en) Diagnostic devices and related methods
ATE520026T1 (de) Sequenzielle analyse biologischer proben
WO2006009728A3 (en) A system for automatically locating and manipulating positions on an object
WO2002040998A3 (de) Kit und verfahren zur multianalytbestimmung
IL287810A (en) Kits for detecting one or more target nucleic acid analytes in a sample and methods of making and using the same
ATE553216T1 (de) Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion
ATE521894T1 (de) Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
ATE541035T1 (de) Modifizierte creatininamid-hydrolase mit verbesserter substrataffinität und reagenszusammensetzung zur bestimmung von creatinin
WO2005064307A3 (en) Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6
WO2010127417A3 (en) Hepatocellular carcinoma
ATE553458T1 (de) Verfahren zur unvorbetonten schätzung der gesamtmenge von objekten auf der basis ungleichförmiger stichproben mit durch verwendung von bildanalyse erhaltener wahrscheinlichkeit
ATE555385T1 (de) N1,n12-diacetylspermin als tumormarker
DE60333876D1 (de) Methoden zum Nachweis Analyten in Proben
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms
EP2012116A4 (de) Verfahren und vorrichtung zur individuellen unterscheidung
ATE409314T1 (de) Verfahren zur beurteilung rheumatoider arthritis durch messen von anti-ccp und serumamyloid a

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties